CorVel Corp. (CRVL)
NEUTRALFondamental
66
Prix
$69.80
Capitalisation boursière
$3.61B
Partie 1 · Ce que vaut l'entreprise
Vue d'ensemble
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Bilan & Liquidités
Chiffre d'affaires
$984M
12 derniers mois (au 30/06/2026)
Résultat net
$115M
12 derniers mois (au 30/06/2026)
Flux de trésorerie libre
$110M
Capitaux propres totaux
$394M
Passif total
$249M
Ratio de liquidité général
1.94
Couverture des intérêts
-
Dette/EBITDA
0.15
Bénéfice par action
Chiffre d'affaires & Résultat net
Flux de trésorerie libre
Décomposition du résultat
État historique
Marges dans le temps
La dette dans le temps
Le poids de la dette
Grille de la croissance
Croissance — Chiffre d'affaires
Estimation de la juste valeur
Juste valeur
$26.35
Prix actuel
$69.80
Marge de sécurité
-164.9%
Fourchette de juste valeur
$21.89 - $30.80
Méthodes d'estimation
Indicateurs de valorisation
Ratio P/E
31.66
ROE
28.0%
Ratio P/B
8.80
P/FCF
31.61
Marge brute
24.8%
ROIC
-
Radar de rentabilité
Value Creation (Economic Moat)
ROIC
-
WACC
10.3%
ROIC − WACC
-
Critères d'analyse fondamentale
Réussi (14)
- EPS shows upward trend
- Price CAGR 19.12%
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- Low reliance on intangibles
- ROE 29.9%
- Revenue Growth 5Y 11.6%
- Earnings Quality (OCF/NI) 1.31
- Share Dilution -0.8%
- Net Margin Trend 11.7% vs 11.0%
- Piotroski F-Score 7/9
Échoué (7)
- EPS CAGR 0.24%
- Gross Margin 24.8%
- P/FCF 31.61
- P/B Ratio 8.80
- CapEx intensity
- Price below Graham Number
- DCF valuation (Overvalued)
Indisponible (7)
- ROIC NaN%
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- Analyst Consensus (Finnhub)
- Earnings Surprise (no valid data)
- PEG Ratio (need PE > 0 and growth > 0)
Score F de Piotroski
Santé financière solide
Qualité des bénéfices
Qualité élevée : bénéfices soutenus par la trésorerie
Dilution du capital
Rachat d'actions. Favorable aux actionnaires
Gouvernance
Équipe dirigeante
| Nom | Titre | Âge |
|---|---|---|
| Mr. Michael G. Combs | Executive Chair | 61 |
| Mr. Brian S. Nichols | Chief Financial Officer | 44 |
| Ms. Jennifer L. Yoss | Vice President of Accounting | 47 |
| Mr. Maxim Shishin | Chief Information Officer | 50 |
| Mr. Mark E. Bertels | Executive Vice President of Risk Management Services | 62 |
| Ms. Sarah Scott | President & CEO | 48 |
| Ms. Sharon F. O'Connor | Vice President of Legal Services | - |
| Melissa Storan | Vice President of Marketing | - |
| Jason Wheeler | Vice President of Sales & Account Management | - |
| Mr. Jeffrey D. Gurtcheff | Chief Claims Officer | - |
Risque d'audit
4
Risque du conseil
6
Risque de rémunération
5
Risque droits des actionnaires
7
Partie 2 · Le prix et le moment d'entrer
Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.
Latest News
Recent headlines for CRVL, sourced from Markets Gazette.